Several teams of researchers from different institutions are trying to create a universal vaccine against coronavirus. The good news is that clinical trials on human volunteers may begin this year.
If they work, these vaccines can protect people against COVID-19, as well as other coronaviruses such as SARS, MERS and even some viruses that cause colds.
Conserv Bioscience is ready to test a universal vaccine
Conserv Bioscience, a British biotechnology company, has developed an RNA (mRNA) vaccine that can protect against the full range of coronaviruses, said Kimbell Duncan, the company’s CEO. The ultimate goal is to develop a supplement that can be administered every few years to prevent future pandemics. Other scientists, such as epidemiologist Ralph Barrick of the University of North Carolina School of Medicine, are already working on their own vaccines.
The goal is noble, but to achieve it will be a real test
Scientists have been talking about universal coronavirus vaccines for years. Coronaviruses have similarities, such as S proteins (spikelets), which help to infect and infect cells, but a universal vaccine must find an aspect of the coronavirus that is not only identical or at least similar, but also crucial for the survival of these pathogens.
“It’s a real danger, and we have to be very careful.”
The COVID-19 pandemic has accelerated research, so there is some progress. “It is very easy to imagine highly pathogenic strains of coronavirus with a mortality rate of 10-15%, which are almost as transmitted as COVID-19. This is a real danger, and we must be very careful,” Baric explained, according to Futurism.